David Brennan Net Worth & Insider Trades
David Brennan - Director, Alexion Pharmaceuticals Inc
What is David Brennan's Net Worth?
The current estimated net worth of Alexion Pharmaceuticals Inc's Director, David Brennan, is estimated to be about $1.16M . David Brennan owns about 1,268 units of Alexion Pharmaceuticals Inc common stock. In the last 4 years at Alexion Pharmaceuticals Inc, David Brennan has sold an estimated value of $0 worth.
What is David Brennan's Past Insider Trading?
David Brennan's largest purchase order was 500 units , worth over $93.5K on December 16, 2014. In total, David Brennan has made about 3 transactions over 4 years of their time at Alexion Pharmaceuticals Inc. David Brennan usually trades in May, July and December, with the busiest year in 2014.
David R Brennan
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is David Brennan's' Mailing Address?
- Mailing address is C/o Insmed Incorporated 10 Finderne Avenue Bridgewater NJ 08807 NJ
Alexion Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Ludwig Hantson | 2019 | $1,250,000 | - | $15,243,634 | - | $2,430,000 | $24,350 | $18,947,984 |
| Ludwig Hantson | 2018 | $1,200,000 | - | $12,385,168 | - | $2,880,000 | $25,082 | $16,490,250 |
| Ludwig Hantson | 2017 | $900,000 | - | $9,618,758 | $2,282,881 | $2,275,000 | $233,428 | $15,310,067 |
| Aradhana Sarin | 2019 | $651,764 | - | $3,380,763 | - | $813,011 | $31,604 | $4,877,142 |
| Paul Clancy | 2019 | $927,000 | - | $3,863,694 | - | $1,051,218 | $23,832 | $5,865,744 |
| Paul Clancy | 2018 | $900,000 | - | $3,302,761 | - | $1,260,000 | $23,752 | $5,486,513 |
| Paul Clancy | 2017 | $415,385 | $500,000 | $8,799,954 | $1,220,082 | $473,620 | $2,262 | $11,411,303 |
| Brian Goff | 2019 | $740,000 | - | $3,863,694 | - | $923,076 | $20,240 | $5,547,010 |
| Brian Goff | 2018 | $695,250 | - | $3,096,323 | - | $973,350 | $111,873 | $4,876,796 |
| Brian Goff | 2017 | $381,634 | $100,000 | $2,390,026 | $732,899 | $434,380 | $58,787 | $4,097,726 |
| Anne-Marie Law | 2019 | $695,000 | - | $3,622,303 | - | $788,130 | $33,528 | $5,138,961 |
| Anne-Marie Law | 2018 | $650,000 | - | $2,889,885 | - | $910,000 | $846,604 | $5,296,489 |
| Anne-Marie Law | 2017 | $362,500 | $200,000 | $2,300,015 | - | $410,472 | $68,710 | $3,341,697 |
| John Orloff | 2019 | $770,000 | - | $3,863,694 | - | $960,498 | $32,550 | $5,626,742 |
| John Orloff | 2018 | $695,250 | - | $3,096,323 | - | $973,350 | $98,679 | $4,863,602 |
| John Orloff | 2017 | $376,442 | $200,000 | $2,499,995 | - | $472,500 | $80,351 | $3,629,288 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm
What are Alexion Pharmaceuticals Inc's Past Insider Trades?
Alexion Pharmaceuticals Inc's most recent insider trade came on December 21, 2020 by Daniel Bazarko who sold 24,066 units worth $3.8M . In the last 17 years, insiders at Alexion Pharmaceuticals Inc have sold an estimated value of $1.09B and bought an estimated value of $426.64M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Leonard Bell, Director, Stephen Squinto, EVP, and Vikas Sinha, EVP & CFO .
ALEXION PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||